Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn various ways to earn money through gig work. Explore strategies to enhance your income through flexible opportunities.
24,561 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Kick off your week with 10 Sunday reads that translate heavy market chatter into actionable investing moves. Each ite...
A key inflation report this Friday could markets move and set the tone for 2026. This guide breaks down what to watch...
Nvidia’s Jens en Huang just signaled a potential pivot into software stocks as AI optimism hits a softer patch. This ...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Geopolitical tensions are sparking volatility in the helium market. This report explains how a disruption in helium s...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Beyond Meat (BYND) 2026 unfolds with a mix of top-line growth and cost discipline. This analysis breaks down Q1 resul...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
A veteran investor recounts how being wrong about inflation missed a powerful stock rally and details a straightforwa...
A forecast from Microsoft-backed Copilot AI points XRP toward a potential tripling in price by mid-2026, driven by in...